SVM-light Version V5.01-TK-1.5
5 # kernel type
3 # kernel parameter -d 
1 # kernel parameter -g 
1 # kernel parameter -s 
1 # kernel parameter -r 
empty# kernel parameter -u 
0.4 # kernel parameter -L 
1 # kernel parameter -T 
T # kernel parameter -C 
1 # kernel parameter -F 
1 # kernel parameter -S 
0.400000 # kernel parameter -M 
3 # kernel parameter -N 
S # kernel parameter -V 
S # kernel parameter -W 
0 # kernel parameter -U 
60 # highest feature index 
20 # number of training documents 
21 # number of support vectors plus 1 
-0.076939624 # threshold b, each following line is a SV (starting with alpha*y)
-1  |BT| (ROOT (FRAG (NP (NNP (CONCLUSION)))(: (:))(S (NP (PRP$ (Our))(NNS (findings)))(VP (VBP (indicate))(SBAR (IN (that))(S (NP (JJ (canakinumab))(CD (150))(NN (mg)))(VP (VP (VBZ (provides))(NP (JJ (rapid))(CC (and))(JJ (sustained))(NN (pain))(NN (relief)))(PP (IN (in))(NP (NP (NNS (patients)))(PP (IN (with))(NP (JJ (acute))(JJ (gouty))(NN (arthritis)))))))(, (,))(CC (and))(VP (ADVP (RB (significantly)))(VBZ (reduces))(NP (NP (DT (the))(NN (risk)))(PP (IN (of))(NP (NP (JJ (recurrent))(NNS (flares)))(PP (VBN (compared))(PP (IN (with))(NP (JJ (triamcinolone))(NN (acetonide))))))))))))))(. (.)))) |ET|  |BV| 1:-0.37606558 2:-0.98968375 3:-1.3086534 4:-0.19797717 5:0.61884069 6:-0.18436113 7:-1.1196713 8:-0.26311594 9:0.068294778 10:0.9070788 11:0.57643336 12:-0.096424736 13:0.82280266 14:0.31290239 15:-0.57269973 16:-0.30621946 17:-0.60577387 18:-0.35865077 19:-0.31720719 20:-0.87843478 21:0.12997298 22:-0.36133137 23:-0.024779137 24:-0.1437653 25:0.2987231 26:0.26406655 27:-0.22048613 28:-0.41377839 29:-0.15444605 30:-0.33987042 31:-0.59818321 32:0.12493557 33:1.0261 34:1.0466661 35:0.77707338 36:0.54146659 37:0.55499518 38:-0.19842112 39:0.93076724 40:0.067590736 41:-0.19936904 42:0.32243595 43:-0.0030879362 44:0.071017116 45:-0.26696366 46:0.16780879 47:0.092501685 48:0.31595072 49:0.27766907 50:0.26579887 51:-0.23534408 52:0.031535909 53:-0.13199455 54:0.47172502 55:-0.065495931 56:-0.25896275 57:0.46338367 58:0.078523852 59:0.15994987 60:0.025450142  |EV| 
-1  |BT| (ROOT (S (NP (DT (The))(NN (plasma))(NN (lipid))(NN (peroxidation)))(VP (VP (VBD (was))(VP (VBN (determined))(CC (and))(VBN (reported))(PP (IN (as))(NP (JJ (thiobarbituric))(NN (acid))(NN (reactive))(NN (substance))))))(CC (and))(VP (VBD (was))(ADJP (ADJP (ADJP (RB (significantly))(JJ (increased)))(PRN (-LRB- (-LRB-))(NP (CD (+21))(NN (%)))(-RRB- (-RRB-))))(, (,))(SBAR (IN (whereas))(S (NP (NP (DT (the))(NNS (activities)))(PP (IN (of))(NP (NP (DT (the))(JJ (erythrocyte))(JJ (antioxidant))(NNS (enzymes))(NN (glutathione)))(ADJP (JJ (peroxidase))(, (,))(JJ (catalase))(, (,))(CC (and))(JJ (superoxide))(JJ (dismutase))))))(VP (VBD (were))(ADVP (RB (significantly)))(VP (VBN (decreased))(PRN (-LRB- (-LRB-))(NP (NP (NP (CD (-32))(NN (%)))(, (,))(NP (CD (-14))(NN (%)))(CC (and))(NP (CD (-31))(NN (%))))(, (,))(ADVP (RB (respectively))))(-RRB- (-RRB-))))))))(PP (IN (in))(NP (JJ (amphetamine))(NNS (users))))))(. (.)))) |ET|  |BV| 1:-0.92916328 2:-0.65497798 3:0.35617489 4:-0.45587307 5:0.060135704 6:0.19588438 7:0.50961417 8:-0.89341038 9:0.3106674 10:-0.20344064 11:-0.11645536 12:-0.36118361 13:0.31257951 14:-0.54843986 15:0.049418435 16:-0.12085623 17:0.14258489 18:0.5083124 19:0.17926449 20:1.3592006 21:-1.6093783 22:1.3398967 23:0.38611811 24:-0.65516007 25:-1.4442043 26:-2.2852452 27:-0.11010057 28:-0.5192399 29:-0.51099622 30:0.29329109 31:-0.25722641 32:-0.66947961 33:-0.23680201 34:0.60405034 35:0.12326748 36:0.16084637 37:-2.1380987 38:0.25952715 39:0.77048397 40:-0.13106576 41:0.52083755 42:-0.038712241 43:0.012037449 44:0.25530264 45:0.48063686 46:0.11514538 47:-0.73532796 48:-0.018298846 49:0.3058472 50:0.11383037 51:0.33107364 52:0.36646381 53:0.22680013 54:-0.55192482 55:-0.19614869 56:0.51874316 57:0.34248555 58:0.257442 59:-0.73391634 60:0.4403266  |EV| 
-1  |BT| (ROOT (S (NP (NP (NNS (Millions)))(PP (IN (of))(NP (NNS (individuals)))))(VP (VBP (are))(VP (VBN (prescribed))(S (NP (NP (JJ (platelet))(NNS (inhibitors)))(, (,))(PP (JJ (such))(IN (as))(NP (NN (aspirin))(CC (and))(NN (clopidogrel))))(, (,)))(VP (TO (to))(VP (VB (reduce))(NP (NP (PRP$ (their))(NN (risk)))(PP (IN (of))(NP (JJ (thrombosis-related))(JJ (clinical))(NNS (events))))))))))(. (.)))) |ET|  |BV| 1:0.36568233 2:0.43306017 3:-0.17580158 4:-0.6000331 5:0.50674915 6:-0.013537247 7:-0.68841088 8:-1.1502311 9:0.041962627 10:-0.3533341 11:-0.18861438 12:-0.28136554 13:0.40990454 14:-0.2373196 15:-0.099518508 16:1.2125367 17:0.37854913 18:0.079171076 19:0.19813041 20:0.08819212 21:-0.12336908 22:0.50790524 23:-0.13482086 24:0.10153528 25:0.21373799 26:0.098185867 27:-0.50570959 28:-1.3714907 29:-0.10674095 30:-0.27715075 31:0.13255547 32:0.072891794 33:0.46582696 34:-0.38309729 35:0.18358243 36:0.4595432 37:-0.26543963 38:-0.55508041 39:0.17575739 40:-0.10054485 41:0.12033847 42:0.2649067 43:0.1314168 44:0.05832861 45:0.40865481 46:-0.012750127 47:-0.047856979 48:0.33570892 49:0.27658409 50:0.14986685 51:0.0090538049 52:-0.30842206 53:-0.15233743 54:0.06448172 55:0.50966096 56:0.33995339 57:0.21784794 58:-0.053466294 59:0.15913945 60:-0.23980552  |EV| 
-1  |BT| (ROOT (S (S (NP (DT (The))(JJ (cyclooxygenase))(NN (inhibitor))(NN (indomethacin)))(VP (VBD (normalized))(NP (DT (this))(NN (response)))))(, (,))(CC (and))(S (NP (NP (DT (the))(NN (concentration)))(PP (IN (of))(NP (NP (DT (the))(JJ (stable))(NN (metabolite)))(PP (IN (of))(NP (NP (NN (prostacyclin)))(PP (IN (in))(NP (NP (DT (the))(NN (aorta)))(PP (IN (of))(NP (NNP (CLP))(NNS (rats)))))))))))(VP (VBD (increased))(PP (PP (IN (in))(NP (JJ (basal))(NNS (conditions))))(CC (and))(PP (IN (after))(NP (NN (stimulation)))))(PP (IN (with))(NP (NN (acetylcholine))))))(. (.)))) |ET|  |BV| 1:-0.32078728 2:0.037484568 3:1.1264472 4:0.41724539 5:-0.53403252 6:-0.22576772 7:0.50058997 8:0.052115172 9:0.79058003 10:-0.74488235 11:-0.10959451 12:-1.0137495 13:1.0401568 14:-0.076530211 15:-0.24698777 16:0.40208021 17:-0.37674373 18:0.18112071 19:0.49860096 20:0.22933872 21:-0.61336213 22:0.02679923 23:0.068499155 24:-0.62354034 25:0.35435158 26:-0.062053744 27:-0.055724088 28:-0.46711007 29:-0.14773609 30:0.71919316 31:0.074955724 32:-0.24812144 33:0.090580061 34:0.011961645 35:-0.16195163 36:0.0082479771 37:-0.0090443175 38:-0.55247039 39:-0.16955894 40:0.34618071 41:-0.35200512 42:-0.28594872 43:0.06200004 44:-0.27340224 45:0.25355029 46:-0.12174217 47:-0.42320728 48:-0.31688699 49:0.10799074 50:0.30800828 51:0.10524759 52:-0.38205194 53:-0.0191561 54:-0.6690886 55:-0.19582961 56:-0.086639866 57:-0.2888346 58:0.016247867 59:-0.080722086 60:0.19382708  |EV| 
-0.87643732012511521567432737356285  |BT| (ROOT (S (S (NP (NNP (Plasma))(NNP (calcium)))(VP (VBD (did))(RB (not))(VP (VB (change)))))(, (,))(CC (but))(S (NP (NNS (concentrations)))(VP (ADVP (IN (of)))(VBZ (insulin))(-LRB- (-LRB-))(NP (NNP (P)))))(. (?)))) |ET|  |BV| 1:-0.75040692 2:0.020162459 3:0.27348629 4:0.05399951 5:0.2677533 6:-0.77832818 7:-0.19949198 8:-0.41161218 9:0.34534886 10:-0.28340191 11:0.036657922 12:-0.64385879 13:-0.040026322 14:0.11968844 15:-1.1066912 16:-0.51416171 17:-0.28275344 18:-0.27895087 19:0.030466164 20:-0.063481063 21:0.22455569 22:-0.060367934 23:-0.3535656 24:0.23816685 25:0.72405118 26:-0.098974265 27:0.17775124 28:0.15778233 29:-0.43578091 30:-0.15931758 31:0.49679017 32:-0.40500918 33:0.61904848 34:-0.056122612 35:0.43520764 36:1.0423833 37:-1.0226662 38:-0.20010051 39:-0.022374308 40:-0.4220525 41:-0.0065368898 42:-0.02392699 43:0.51572824 44:0.24083543 45:0.22842298 46:0.3134948 47:-0.46996632 48:0.43399221 49:0.018011013 50:-0.20035103 51:-0.06200169 52:-0.38922286 53:0.329864 54:-0.15121588 55:0.052663375 56:0.39468268 57:0.67480797 58:-0.041231856 59:0.28454468 60:0.32026505  |EV| 
1  |BT| (ROOT (S (NP (NP (NP (NN (Monitoring))(NNS (patients)))(PP (IN (for))(NP (JJ (adverse))(NNS (events)))))(, (,))(NP (NP (DT (the))(NN (need)))(PP (IN (for))(NP (NN (dose))(NNS (adjustments)))))(, (,))(CC (or))(NP (NP (DT (both)))(PP (IN (during))(NP (NP (NN (coadministration)))(PP (IN (with))(NP (NN (posaconazole))))))))(VP (MD (may))(VP (VB (be))(VP (VBN (warranted))(PP (IN (in))(NP (NP (NNS (patients)))(VP (VBG (being))(VP (VBN (treated))(PP (IN (with))(NP (NP (NNS (benzodiazepines)))(SBAR (WHNP (WDT (that)))(S (VP (VBP (are))(ADVP (RB (predominantly)))(VP (VBN (metabolized))(PP (IN (through))(NP (NNP (CYP3A4))))))))(PRN (-LRB- (-LRB-))(NP (NP (NN (eg)))(, (,))(NP (NN (midazolam))))(-RRB- (-RRB-))))))))))))(. (.)))) |ET|  |BV| 1:-0.28265727 2:0.0656562 3:-0.93843931 4:-0.28390467 5:0.59602314 6:0.36759615 7:-0.56220162 8:-0.53475237 9:0.19146045 10:-0.030946651 11:-0.57119101 12:-0.25434497 13:-0.98948151 14:0.28517544 15:0.020439416 16:0.49218255 17:-1.1002952 18:-0.30565166 19:0.73247087 20:0.57006592 21:0.14655669 22:-0.45460272 23:-0.82272255 24:-1.2020403 25:0.40969881 26:-0.028693192 27:-1.8421614 28:0.12895726 29:0.019132346 30:-0.4566274 31:0.70700163 32:-0.21630909 33:0.36099231 34:0.41638753 35:-0.30120116 36:0.92217582 37:-0.13713595 38:-0.077099934 39:1.1878256 40:-0.22765183 41:-0.051838785 42:0.033334572 43:-0.42181465 44:-0.36045054 45:-0.035379484 46:0.067820132 47:0.33820021 48:0.4221029 49:0.33571532 50:0.34134811 51:0.0040408904 52:0.15628727 53:0.3386983 54:1.0346943 55:0.32294279 56:-0.36312634 57:-0.031760685 58:0.35327691 59:0.022950394 60:-0.39523703  |EV| 
1  |BT| (ROOT (S (NP (NP (NP (NNS (CONCLUSIONS)))(: (:))(NP (NP (NP (JJ (High))(NN (clonidine))(NN (dose)))(PRN (-LRB- (-LRB-))(NP (CD (75))(NN (microg)))(-RRB- (-RRB-))))(VP (VBN (associated))(PP (TO (to))(NP (JJ (hyperbaric))(NN (bupivacaine))))(PP (IN (during))(NP (JJ (high-level))(JJ (spinal))(NN (anesthesia)))))))(PRN (-LRB- (-LRB-))(NP (NNP (T4)))(-RRB- (-RRB-))))(VP (VP (VBZ (induces))(NP (NP (DT (a))(JJR (higher))(NN (incidence)))(PP (IN (of))(NP (JJ (arterial))(NN (hypotension))))))(CC (but))(VP (VBZ (prolongs))(NP (NP (JJ (sensory))(NN (block))(CC (and))(NN (postoperative))(NN (analgesia)))(ADJP (JJ (similar))(PP (TO (to))(NP (JJR (lower))(NN (clonidine))(NN (dose)))))(PRN (-LRB- (-LRB-))(NP (CD (45))(NN (microg)))(-RRB- (-RRB-))))(PP (IN (during))(NP (JJ (upper))(JJ (spinal))(NN (anesthesia))))))(. (.)))) |ET|  |BV| 1:-0.29904887 2:-0.22526118 3:-0.09008126 4:-0.13910386 5:-0.31144923 6:0.17207734 7:-0.039948009 8:0.079204179 9:0.70163774 10:-0.36017191 11:0.17597541 12:-0.57637811 13:0.14167736 14:-0.25525403 15:-0.73161376 16:0.41381264 17:0.29035079 18:0.30363902 19:0.30704567 20:0.28261095 21:-0.53686792 22:-0.36265847 23:-0.65683991 24:-0.17644718 25:-0.39572138 26:-0.02043424 27:0.3968665 28:-0.06179741 29:0.27820352 30:-0.39679688 31:-0.32952511 32:-0.031053193 33:0.72736406 34:0.039911401 35:-0.64438587 36:-0.074191868 37:0.17469947 38:0.078050599 39:-0.046043083 40:0.11950891 41:-0.8775115 42:0.46209773 43:-0.044583268 44:-0.37638709 45:0.35103029 46:-0.24295102 47:-0.89328033 48:-0.17133319 49:0.049200304 50:-0.032217477 51:-0.017013328 52:-0.40208656 53:-0.45769954 54:0.22057317 55:-0.32157007 56:-0.56234401 57:-0.037736695 58:0.19900319 59:-0.3273215 60:-0.043248381  |EV| 
1  |BT| (ROOT (S (S (VP (VBG (Examining))(NP (NP (DT (the))(NNS (details)))(PP (IN (of))(NP (NP (DT (the))(JJ (temporal))(NNS (features)))(PP (IN (of))(NP (DT (the))(JJ (evoked))(NNS (profiles)))))))))(VP (VBZ (reveals))(NP (NP (DT (no))(JJ (clear))(NN (evidence)))(PP (IN (for))(NP (NP (JJ (long-distance))(NN (diffusion)))(PP (IN (of))(NP (NP (NN (dopamine)))(PP (IN (between))(NP (ADJP (JJ (fast))(CC (and))(JJ (slow)))(NNS (domains)))))))))(, (,))(SBAR (RB (even))(IN (though))(S (NP (NP (JJ (uptake))(NN (inhibition)))(PP (IN (by))(NP (NN (nomifensine)))))(VP (ADVP (RB (clearly)))(VBZ (prolongs))(NP (DT (the))(NN (time)))(SBAR (IN (that))(S (NP (NN (dopamine)))(VP (VBZ (resides))(PP (IN (in))(NP (DT (the))(NN (extracellular))(NN (space)))))))))))(. (.)))) |ET|  |BV| 1:-1.0784909 2:0.065523647 3:0.3956686 4:-0.49036288 5:-1.1238351 6:0.62183082 7:1.2141268 8:-0.87749398 9:0.7004292 10:0.17572528 11:-1.5038565 12:-0.79752553 13:1.9166946 14:0.015967619 15:-0.037941515 16:0.71259588 17:-0.16304232 18:0.93659019 19:0.5446707 20:0.50377518 21:-0.60204566 22:-0.35711971 23:0.85985899 24:0.27446148 25:-0.20846319 26:0.014145992 27:0.70121819 28:-0.15712686 29:0.53265935 30:0.23197278 31:-0.3773756 32:-0.9809835 33:0.6999554 34:-0.076202594 35:-0.036084212 36:0.60930538 37:-0.1530766 38:0.047351845 39:0.38941315 40:0.12008921 41:-0.0072809439 42:0.096122377 43:-0.060230538 44:-0.38754225 45:0.0091935098 46:-0.52696037 47:0.392652 48:-0.26224971 49:-0.35087907 50:0.57207578 51:-0.12182883 52:-0.066432878 53:0.12815899 54:-0.32323053 55:0.20110478 56:0.28769302 57:0.41468632 58:0.24735659 59:-0.3719531 60:0.15246236  |EV| 
1  |BT| (ROOT (S (NP (NNP (Chlordiazepoxide)))(VP (VBD (produced))(NP (JJ (significant))(NNS (decreases)))(PP (PP (IN (in))(NP (NP (JJ (food-maintained))(VBG (responding)))(CC (and))(NP (NP (DT (the))(NN (dose)))(PP (IN (of))(NP (NP (NN (ethanol)))(VP (VBN (presented))))))))(, (,))(CONJP (CC (but))(RB (only)))(PP (IN (at))(NP (NP (DT (the))(JJS (highest))(NN (dose)))(VP (VBN (tested)))))))(. (.)))) |ET|  |BV| 1:-0.46602055 2:-0.21592917 3:-0.01621655 4:-0.59530169 5:0.017989574 6:-0.39869586 7:-0.12921393 8:-0.5450719 9:0.22623292 10:-0.47821143 11:-0.15223412 12:0.12070277 13:0.2351961 14:0.11936298 15:0.46216598 16:0.37476248 17:0.079642236 18:0.4013584 19:-0.40950754 20:0.51730853 21:-1.7143559 22:0.30031815 23:-0.43550092 24:-0.50318384 25:1.2049383 26:-1.032849 27:-1.5394974 28:-0.24475566 29:1.2570802 30:-0.030677823 31:0.1726388 32:-0.5722056 33:0.33783394 34:0.24078596 35:0.39701006 36:-0.24349047 37:0.0037306917 38:1.2287591 39:-0.26145151 40:0.79690206 41:-0.18141213 42:-0.34776458 43:0.23550238 44:-0.057214998 45:-0.059985306 46:-0.018314809 47:0.26424554 48:-0.11518739 49:-0.14732754 50:-0.050291035 51:-0.3898859 52:0.039977197 53:0.061775573 54:0.39059895 55:-0.033019111 56:0.16880378 57:0.86010063 58:0.16323142 59:-0.0095216176 60:0.44171008  |EV| 
1  |BT| (ROOT (NP (NP (NNS (CONCLUSIONS)))(: (:))(NP (NP (DT (The))(NN (combination)))(PP (IN (of))(NP (NP (JJ (chronic))(ADJP (JJ (amiodarone))(CC (and))(JJ (acute)))(NN (ranolazine)))(SBAR (S (VP (VBZ (produces))(NP (NP (DT (a))(JJ (synergistic))(JJ (use-dependent))(NN (depression)))(PP (IN (of))(NP (NP (PRP (I)))(PRN (-LRB- (-LRB-))(NP (NNP (Na)))(-RRB- (-RRB-))))))))))))(: (-))(NP (NP (JJ (dependent))(NNS (parameters)))(PP (IN (in))(NP (JJ (isolated))(JJ (canine))(NN (atria)))))(, (,))(VP (VBG (leading))(PP (TO (to))(NP (NP (DT (a))(JJ (potent))(NN (effect)))(PP (IN (of))(NP (DT (the))(NN (drug))(NN (combination))))))(S (VP (TO (to))(VP (VB (prevent))(NP (NP (DT (the))(NN (induction)))(PP (IN (of))(NP (JJ (atrial))(NN (fibrillation)))))))))(. (.)))) |ET|  |BV| 1:-0.26869521 2:0.074608646 3:-0.22802867 4:-0.48472789 5:0.63233221 6:0.23110741 7:0.083076008 8:-0.74931037 9:-0.0094308779 10:0.092594057 11:-0.060885035 12:-0.68561119 13:0.048782356 14:-0.089420348 15:0.10601293 16:0.20184861 17:0.077158615 18:-0.12989041 19:0.040844664 20:0.15073103 21:-0.70580858 22:-0.053783413 23:0.43799111 24:-1.4790112 25:0.43420908 26:-0.29118481 27:0.10539491 28:-0.85323501 29:0.98174053 30:0.81241155 31:-0.63296944 32:-1.6195498 33:-0.19073492 34:0.70346892 35:-0.63045532 36:0.087741509 37:0.15460868 38:0.16657747 39:0.25416797 40:0.051111761 41:-0.41923228 42:-0.076682195 43:0.058075078 44:0.0017298945 45:-0.12801126 46:-0.45787504 47:0.14818916 48:0.16364421 49:0.28118056 50:-0.093474999 51:-0.09365011 52:-0.81058794 53:0.0079124523 54:0.085630432 55:-0.022426182 56:0.24418865 57:0.23249947 58:-0.084500901 59:0.20859201 60:-0.58434063  |EV| 
-1  |BT| (ROOT (S (NP (NP (NP (NNP (Tolvaptan)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (TOL)))(: (;))(NP (JJ (selective))(NN (V2))(NN (antagonist))))(-RRB- (-RRB-))))(CC (and))(NP (NP (NNP (Conivaptan)))(PRN (-LRB- (-LRB-))(NP (NP (NNP (CON)))(: (;))(NP (JJ (dual))(JJ (V1a/V2))(NN (antagonist))))(-RRB- (-RRB-)))))(VP (VBP (are))(NP (NP (CD (two))(NNP (AVP))(NNS (antagonists)))(SBAR (WHNP (WDT (that)))(S (VP (VB (counteract))(NP (NP (DT (the))(NN (action)))(PP (IN (of))(NP (NNP (AVP)))))(PP (IN (with))(NP (JJ (distinct))(NNS (profiles)))))))))(. (.)))) |ET|  |BV| 1:-0.39046875 2:-0.45979622 3:0.99363053 4:-0.21541928 5:0.23829918 6:0.28456715 7:0.98986179 8:0.80647457 9:0.51785159 10:-0.79126203 11:0.9484719 12:-0.56193447 13:0.1061158 14:0.37001076 15:0.64013845 16:1.2111628 17:-0.3526122 18:-1.5711068 19:0.1136772 20:0.69866449 21:0.25215793 22:-0.62558365 23:1.1852509 24:-0.51845771 25:0.1369665 26:0.41037267 27:0.6015467 28:0.87852597 29:-0.014440944 30:-0.41032562 31:0.9008736 32:-0.24733737 33:0.63471246 34:0.15007168 35:-0.046180271 36:0.76722103 37:-0.29832548 38:-1.1883965 39:0.034129493 40:0.38769397 41:0.015025906 42:-0.62695068 43:0.51239902 44:0.10427199 45:0.30972534 46:-0.24865332 47:0.22387283 48:-0.15668352 49:-0.28722873 50:-0.067728087 51:0.22515543 52:-0.24518691 53:-0.096236669 54:-0.20849133 55:-0.0075168256 56:0.96002591 57:0.1579304 58:0.12198612 59:-0.26210397 60:0.021933628  |EV| 
-1  |BT| (ROOT (S (NP (DT (The))(NP (NNP (Nicotrol))(NNP (®))(PRN (-LRB- (-LRB-))(NP (NNP (Pfizer)))(, (,))(NP (NNP (USA)))(-RRB- (-RRB-)))(NNP (nicotine)))(NN (inhaler)))(VP (VBZ (reduces))(NP (NN (craving)))(PP (IN (by))(S (VP (VP (VBG (mimicking))(NP (NP (DT (the))(JJ (behavioural))(NN (component)))(PP (IN (of))(NP (NNS (cigarettes))))))(CC (and))(VP (VBG (delivering))(NP (NP (JJ (controlled))(NNS (doses)))(PP (IN (of))(NP (NP (NN (nicotine)))(, (,))(SBAR (WHNP (WDT (which)))(S (VP (VBZ (binds))(PP (TO (to))(NP (NP (DT (the))(JJ (beta-2))(JJ (subunit-containing))(JJ (nicotinic))(NN (acetylcholine))(NNS (receptors)))(PRN (-LRB- (-LRB-))(NP (NP (JJ (ß2))(NNS (*)))(: (-))(NP (NNS (nAChRs))))(-RRB- (-RRB-))))))))))))))))(. (.)))) |ET|  |BV| 1:-0.46931008 2:-0.56677818 3:0.017596226 4:0.45304894 5:-0.20811825 6:0.36912087 7:0.024736561 8:-0.3624849 9:1.1619563 10:0.26304698 11:0.10815388 12:-0.4853164 13:-0.012879913 14:-0.63843131 15:-0.38840893 16:1.0427612 17:0.13412921 18:0.52470136 19:0.13751529 20:0.011056054 21:-0.32078728 22:0.037484568 23:1.1264472 24:0.41724539 25:-0.53403252 26:-0.22576772 27:0.50058997 28:0.052115172 29:0.79058003 30:-0.74488235 31:-0.10959451 32:-1.0137495 33:1.0401568 34:-0.076530211 35:-0.24698777 36:0.40208021 37:-0.37674373 38:0.18112071 39:0.49860096 40:0.22933872 41:0.20284788 42:-0.3561368 43:0.084891312 44:-0.43526301 45:0.14263298 46:-0.057887509 47:-0.41362166 48:0.27071723 49:-0.16649103 50:0.54745346 51:0.27720225 52:-0.17772934 53:0.07782004 54:0.36254105 55:0.096472614 56:0.35221466 57:-0.0034735969 58:0.059540264 59:-0.26621389 60:0.28380531  |EV| 
-1  |BT| (ROOT (S (NP (NP (DT (The))(NN (breast))(NN (cancer))(NN (cell))(NN (line))(NN (MCF7)))(CC (and))(NP (DT (the))(NN (lung))(NN (cancer))(NN (cell))(NN (line))(NN (H1299))))(VP (VBD (were))(VP (VBN (treated))(PP (IN (with))(NP (JJ (usnic))(NN (acid))(CD (29))(NN (microM))))(PP (IN (for))(NP (NP (NP (CD (24))(NNS (hours)))(CC (and))(NP (CD (two))(JJ (positive))(NNS (controls))))(: (:))(NP (NP (NN (vincristine)))(PRN (-LRB- (-LRB-))(SBAR (WHNP (WDT (which)))(S (VP (VBZ (prevents))(NP (NP (DT (the))(NN (formation)))(PP (IN (of))(NP (NNS (microtubules))))))))(-RRB- (-RRB-))))(CC (or))(NP (NP (NN (taxol)))(PRN (-LRB- (-LRB-))(SBAR (WHNP (WDT (which)))(S (VP (VBZ (stabilizes))(NP (NNS (microtubules))))))(-RRB- (-RRB-))))))))(. (.)))) |ET|  |BV| 1:-0.029320531 2:-0.75977832 3:0.45109543 4:-0.15515347 5:0.64704067 6:-0.15556385 7:0.21244945 8:-0.66351461 9:-0.34376201 10:0.49858737 11:-0.37093538 12:0.21692336 13:-0.015999509 14:0.52653354 15:0.06919641 16:0.31085357 17:0.51628029 18:0.087203391 19:-0.0070593348 20:-0.42671031 21:0.14915241 22:-1.0854794 23:0.7036404 24:0.29362264 25:0.12574691 26:0.5744859 27:1.0867987 28:-0.52343071 29:-0.7781049 30:0.32329974 31:1.2327778 32:0.20953646 33:0.18533657 34:0.017181041 35:1.2195849 36:1.281563 37:-1.0164585 38:-0.96715933 39:-0.12409223 40:-1.0199168 41:0.018269116 42:-0.57038105 43:-0.40217429 44:0.63126153 45:-0.11898898 46:-0.59291732 47:-0.15633908 48:-0.035655659 49:-0.03209503 50:-0.26538646 51:0.035841774 52:0.23713905 53:-0.079335138 54:0.63053089 55:0.21088801 56:0.045045473 57:0.3231636 58:0.16601917 59:0.58093262 60:0.50609863  |EV| 
1  |BT| (ROOT (S (NP (NP (JJ (Several))(NNS (drugs)))(, (,))(PP (VBG (including))(NP (NP (NN (sucralfate)))(, (,))(NP (NN (acarbose)))(, (,))(NP (JJ (cytotoxic))(NNS (agents)))(, (,))(CC (and))(NP (JJ (enzyme))(NNS (inducers)))))(, (,)))(VP (MD (can))(VP (VB (reduce))(NP (JJ (digoxin))(NN (plasma))(NNS (concentrations)))))(. (.)))) |ET|  |BV| 1:-0.81254447 2:0.20673874 3:1.1061985 4:-0.28599989 5:1.3810707 6:-0.28406557 7:0.10761394 8:-0.10644218 9:0.94611996 10:-0.15091638 11:-0.61951691 12:-0.42089882 13:-0.21764337 14:-0.044522028 15:-0.83189547 16:0.3559075 17:-0.89789271 18:-0.90527165 19:-0.18081182 20:0.51909345 21:-0.4926416 22:0.82056272 23:-0.94503522 24:-0.34236881 25:0.91995567 26:-0.34672225 27:-0.62261409 28:-0.4620153 29:0.96278644 30:-0.36687094 31:-0.57406396 32:-0.33771357 33:0.59913725 34:0.16890444 35:-0.17380027 36:0.070051499 37:0.041306898 38:-0.30812877 39:0.0051408666 40:0.16284958 41:0.081307322 42:-0.16081139 43:0.19894342 44:0.24154966 45:0.39339229 46:-0.099985994 47:-0.1451209 48:0.24562296 49:0.69576925 50:0.15581784 51:-0.0079318183 52:-0.34559703 53:0.20081584 54:0.23652399 55:0.56010133 56:-0.024477785 57:0.2513859 58:0.51171845 59:-0.12258974 60:0.17204346  |EV| 
1  |BT| (ROOT (S (NP (PRP$ (Our))(NNS (results)))(VP (VBP (indicate))(SBAR (IN (that))(S (NP (NN (modafinil)))(VP (MD (can))(VP (VP (VB (interfere))(PP (IN (with))(NP (JJ (methamphetamine))(NNS (actions)))))(CC (and))(VP (VB (provide))(NP (NN (protection)))(PP (IN (against))(NP (NP (JJ (dopamine))(NN (toxicity)))(, (,))(NP (NN (cell))(NN (death)))(, (,))(CC (and))(NP (NP (NN (neuroinflammation)))(PP (IN (in))(NP (DT (the))(NN (mouse))(NN (striatum)))))))))))))(. (.)))) |ET|  |BV| 1:-0.14261669 2:-0.55936086 3:0.63991159 4:-0.539074 5:0.31694195 6:0.13253108 7:-0.11247442 8:-0.40818018 9:0.38277 10:-0.067099549 11:0.07630989 12:0.050099548 13:0.23985727 14:-0.0095790215 15:0.27195653 16:0.52697021 17:0.16069002 18:0.66765112 19:0.066552192 20:0.0097477036 21:-0.24680129 22:-0.81274748 23:-0.50071269 24:-0.55885315 25:0.23708303 26:0.15480708 27:-1.672067 28:-0.48279968 29:0.7831471 30:-0.10028727 31:-0.23895875 32:0.8838309 33:0.27339482 34:-0.22491546 35:-0.50619984 36:0.92717606 37:0.11254762 38:2.1390157 39:0.082279883 40:0.42567167 41:0.041540444 42:-0.30314672 43:0.081865966 44:-0.34381428 45:0.50240588 46:-0.42807233 47:0.21069756 48:0.013498738 49:0.23692408 50:0.17192906 51:-0.059071701 52:0.66638595 53:0.40119097 54:-0.15559366 55:0.31869078 56:0.28932792 57:0.02448014 58:-0.258055 59:0.052285697 60:0.26726991  |EV| 
0.96305730041543924357938522007316  |BT| (ROOT (FRAG (NP (NNS (METHODS))(CC (AND))(NNS (RESULTS)))(: (:))(S (NP (NP (JJ (Pravastatin))(PRN (-LRB- (-LRB-))(NP (CD (112))(NN (nmol/L)))(-RRB- (-RRB-)))(NN (pretreatment)))(PP (IN (for))(NP (CD (60))(NN (min)))))(VP (VBD (reduced))(NP (PDT (both))(DT (the))(NN (potency))(CC (and))(JJ (maximal))(NN (constrictor))(NNS (responses)))(PP (TO (to))(NP (NN (phenylephrine))))(, (,))(NP (NP (NN (thromboxane)))(PRN (-LRB- (-LRB-))(NP (NNP (U46619)))(-RRB- (-RRB-)))(CC (and))(NP (NP (NN (serotonin)))(PP (IN (in))(NP (JJ (small))(NNS (vessels))))))))(. (.)))) |ET|  |BV| 1:-0.18197556 2:-0.54523051 3:-0.64101624 4:-0.97040534 5:-0.4327507 6:0.85202593 7:-0.021534624 8:-0.20834669 9:0.083935373 10:-0.087370142 11:-0.042733949 12:-0.91944873 13:0.68082851 14:0.12676443 15:-0.36595321 16:0.29826862 17:-0.42395619 18:0.01336247 19:-0.077209421 20:-0.61046493 21:-0.36161754 22:-0.49986917 23:0.3886624 24:-0.13534401 25:1.199581 26:-1.8528512 27:-0.38970506 28:-0.079606503 29:-0.57216412 30:-1.0893993 31:0.12762265 32:-0.17020705 33:0.85830241 34:-0.64155644 35:0.16839691 36:0.77734941 37:0.52667135 38:-0.90320146 39:0.43845496 40:-0.92112947 41:-0.40223062 42:0.060950503 43:-0.022601483 44:0.12554786 45:-0.24916542 46:-0.19692834 47:0.26483575 48:-0.045879256 49:-0.064833462 50:0.27622718 51:0.16834944 52:-0.25994578 53:-0.11487827 54:0.08512862 55:-0.39566091 56:0.60141969 57:-0.065543666 58:-0.29085553 59:-0.47284815 60:-0.11728239  |EV| 
-1  |BT| (ROOT (S (NP (DT (These))(NNS (results)))(VP (VP (VBP (indicate))(NP (NP (DT (a))(JJ (major))(NN (role)))(PP (IN (of))(NP (NP (NN (acetylcholine)))(PP (IN (in))(NP (JJ (airway))(NN (inflammation))(CC (and))(NN (remodelling))))))(PP (IN (in))(NP (DT (a))(NNP (GORD))(NN (model))))))(, (,))(CC (and))(VP (VBP (demonstrate))(SBAR (IN (that))(S (NP (NN (tiotropium))(CC (and))(NN (atropine)))(VP (MD (can))(VP (VB (prevent))(NP (NN (lung))(NN (inflammation)))(PP (IN (with))(NP (NP (DT (an))(NN (effectiveness)))(ADJP (JJ (similar))(PP (TO (to))(NP (JJ (intraperitoneal))(NN (dexamethasone)))))))(, (,))(S (VP (VBG (providing))(NP (JJ (additional))(NN (evidence)))(SBAR (IN (that))(S (NP (NNS (anticholinergics)))(VP (MD (might))(VP (VB (contribute))(PP (TO (to))(NP (NP (DT (the))(NN (control)))(PP (IN (of))(NP (NP (JJ (inflammatory))(NNS (processes)))(PP (IN (in))(NP (JJ (airway))(NNS (diseases))))))))))))))))))))(. (.)))) |ET|  |BV| 1:-0.66035336 2:-0.73338765 3:-0.25485098 4:-0.23102337 5:-0.02112316 6:0.33654544 7:0.092107899 8:-0.08000952 9:0.17193818 10:-0.27053556 11:0.14222904 12:-0.21222526 13:0.31958082 14:0.098712504 15:-0.68598586 16:0.32866085 17:-0.25476411 18:-0.088467598 19:0.36808419 20:0.35060009 21:-0.30543125 22:-0.68493575 23:0.14094806 24:-0.41298282 25:0.069823265 26:0.066800371 27:-0.61645758 28:-0.33678678 29:-0.46005759 30:0.69693571 31:-0.080697224 32:0.20200713 33:0.32868925 34:0.074383281 35:-0.20272613 36:0.42667001 37:-0.088687405 38:-0.096450709 39:0.47324693 40:-0.12706025 41:0.28405172 42:-0.46918011 43:-0.22503027 44:-0.37517297 45:0.13766593 46:-0.54878187 47:0.096516892 48:-0.089377575 49:0.40917584 50:-0.040719181 51:-0.3589679 52:-0.57289362 53:0.081202991 54:0.21893403 55:0.46069345 56:0.28304675 57:0.37615681 58:0.18583581 59:-0.34815693 60:0.3828795  |EV| 
-1  |BT| (ROOT (S (ADVP (RB (Recently)))(NP (PRP (it)))(VP (VBZ (has))(VP (VBN (been))(VP (VBN (demonstrated))(SBAR (IN (that))(S (NP (NP (NNS (mutations)))(PP (IN (in))(NP (NNP (KRAS)))))(VP (VBP (predict))(NP (NP (DT (the))(NN (efficacy)))(PP (IN (of))(NP (NN (panitumumab))(CC (and))(NN (cetuximab)))))(, (,))(S (VP (VP (VBG (limiting))(NP (PRP$ (their))(NN (use))(S (VP (TO (to))(VP (VB (CRC))(NP (NNS (patients)))(PP (IN (with))(NP (JJ (wild-type))(NNS (KRAS)))))))))(, (,))(CC (and))(VP (VBG (moving))(NP (NP (DT (the))(JJ (clinical))(NN (field)))(PP (IN (towards))(NP (VBN (personalized))(NN (cancer))(NN (care))))))))))))))(. (.)))) |ET|  |BV| 1:0.84383363 2:-0.75469607 3:0.95167935 4:0.058287829 5:1.1593744 6:-1.0484579 7:-0.19120936 8:0.34087211 9:0.13894634 10:0.99016362 11:-0.24127068 12:0.39808917 13:-0.23044524 14:1.3463773 15:0.62295705 16:0.75348425 17:-0.37802628 18:-1.0510933 19:0.43460208 20:0.40341219 21:0.30881372 22:-0.65056902 23:0.29194072 24:0.58987886 25:0.62605762 26:0.23110878 27:-0.50380301 28:-0.24104731 29:0.81242853 30:0.51628977 31:-0.056835424 32:0.022828998 33:0.35844028 34:0.83218277 35:-0.5408392 36:1.1524553 37:-0.79680634 38:-1.0331056 39:0.013050469 40:-0.4568955 41:0.19825087 42:-0.010404584 43:-0.065726086 44:-0.026158174 45:0.080881707 46:-0.25682849 47:0.044837944 48:-0.2393661 49:0.15344611 50:0.34563282 51:0.3661361 52:-0.047217552 53:0.016249532 54:0.25333515 55:0.42758057 56:0.10758886 57:-0.165443 58:0.097635925 59:0.35737514 60:0.18461587  |EV| 
0.91338273442952289116192332585342  |BT| (ROOT (S (NP (NP (NNP (CONCLUSIONS))(CC (AND))(NNP (POTENTIAL))(NNP (RELEVANCE)))(: (:))(NP (NP (DT (A))(JJ (dexmedetomidine))(NN (CRI)))(PP (IN (at))(NP (DT (the))(VBN (reported))(NN (dose))))))(ADVP (RB (significantly)))(VP (VBZ (reduces))(NP (NP (DT (the))(NX (NNP (MAC))))(PP (IN (of))(NP (NN (sevoflurane))))))(. (.)))) |ET|  |BV| 1:-0.40540919 2:-0.80014783 3:-0.60397154 4:-0.74242026 5:0.60227066 6:0.29311493 7:-0.35135466 8:-0.19728729 9:0.32011387 10:-0.5253188 11:-0.45022595 12:-0.070499688 13:0.90484536 14:0.57034105 15:-1.0817698 16:-0.18629347 17:0.95865798 18:0.27066278 19:0.63845855 20:-1.3072873 21:-0.60257518 22:-0.17956254 23:-0.64469415 24:-0.76035488 25:0.4125036 26:-0.19416803 27:0.074797876 28:0.33812881 29:0.20420709 30:-0.622747 31:-0.47510663 32:0.13519731 33:1.0633824 34:-0.82755607 35:-0.63239121 36:-0.4709318 37:0.15678918 38:-0.13461971 39:0.21139063 40:-0.068766534 41:0.070837721 42:-0.041178554 43:-0.21320058 44:-0.19575028 45:0.12844932 46:-0.14372426 47:0.30233124 48:0.36507204 49:0.19902021 50:0.074004412 51:-0.024882922 52:-0.46476805 53:0.02908759 54:0.38138312 55:-0.18820947 56:0.45067769 57:0.60547256 58:-0.080025941 59:0.015638461 60:0.18853976  |EV| 
1  |BT| (ROOT (NP (NP (NNP (Antagonism)))(PP (IN (of))(NP (NP (DT (the))(ADJP (JJ (antithrombotic))(CC (and))(JJ (anti-atherosclerotic)))(NNS (actions)))(PP (IN (of))(NP (NN (aspirin))))))(PP (IN (by))(NP (NN (rofecoxib))))(PP (IN (in))(NP (DT (the))(JJ (cholesterol-fed))(NN (rabbit))))(. (.)))) |ET|  |BV| 1:-0.47262436 2:-0.48804033 3:-0.39330533 4:0.052931417 5:-0.1368902 6:0.41303182 7:-0.73690993 8:-0.68806005 9:0.88663203 10:-1.2537808 11:0.024382414 12:0.68279886 13:0.28529304 14:-2.7568395 15:0.40701726 16:1.0172617 17:-1.582556 18:-0.89909738 19:0.73381996 20:-0.079010613 21:-0.12336908 22:0.50790524 23:-0.13482086 24:0.10153528 25:0.21373799 26:0.098185867 27:-0.50570959 28:-1.3714907 29:-0.10674095 30:-0.27715075 31:0.13255547 32:0.072891794 33:0.46582696 34:-0.38309729 35:0.18358243 36:0.4595432 37:-0.26543963 38:-0.55508041 39:0.17575739 40:-0.10054485 41:0.18249582 42:-0.084802166 43:-0.13706894 44:-0.34044096 45:0.33302096 46:-0.19136234 47:-0.042030893 48:-0.11687087 49:0.20684583 50:0.30375752 51:-0.073125973 52:0.20955433 53:0.10662958 54:-0.013420646 55:-0.12044682 56:0.54721409 57:0.50125366 58:0.041446693 59:-0.20325141 60:0.12205698  |EV| 
